Beijing Tsinghua Chang Gung Hospital
Clinical trials sponsored by Beijing Tsinghua Chang Gung Hospital, explained in plain language.
-
Heated chemotherapy showdown: one round or three for rare abdominal cancer?
Disease control Recruiting nowThis study tests whether giving three rounds of heated chemotherapy (HIPEC) after surgery is better than one round for people with pseudomyxoma peritonei, a rare abdominal cancer. About 132 adults will be randomly assigned to one or three HIPEC sessions. Researchers will track su…
Phase: NA • Sponsor: Beijing Tsinghua Chang Gung Hospital • Aim: Disease control
Last updated May 17, 2026 08:19 UTC
-
Lab-Grown tumor models could personalize mesothelioma treatment
Disease control Recruiting nowThis study tests a new way to choose cancer treatments for people with peritoneal mesothelioma. After surgery, a small piece of the tumor is grown in the lab to create a model. Different drugs are tested on this model to find the best one for each patient. The goal is to see if t…
Phase: NA • Sponsor: Beijing Tsinghua Chang Gung Hospital • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Spinal zap may restore bathroom control after paralysis
Disease control Recruiting nowThis study tests whether electrical stimulation of the spinal cord can safely improve bladder and bowel function in people with spinal cord injury. Ten adults with injuries older than 6 months will receive an implanted stimulator and undergo 6 months of therapy. The goal is to se…
Phase: NA • Sponsor: Beijing Tsinghua Chang Gung Hospital • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
New model aims to predict heart damage after liver surgery
Knowledge-focused Recruiting nowThis study is creating a tool to predict heart injury after major liver surgery. Researchers will track 1800 adults to see which factors—like patient health and surgical methods—raise risk. The goal is to help doctors prevent complications and improve recovery.
Sponsor: Beijing Tsinghua Chang Gung Hospital • Aim: Knowledge-focused
Last updated May 07, 2026 18:51 UTC
-
AI boosts liver cancer staging accuracy in new trial
Knowledge-focused Recruiting nowThis study tests whether an artificial intelligence (AI) tool can help doctors more accurately stage and plan treatment for liver cancer (hepatocellular carcinoma). About 108 patients and their doctors will participate, with some doctors using the AI tool and others not. The goal…
Sponsor: Beijing Tsinghua Chang Gung Hospital • Aim: Knowledge-focused
Last updated May 05, 2026 11:53 UTC